A randomized clinical trial:耳针配合拔罐治疗更能改善慢性背痛

2021-08-11 August MedSci原创

慢性背痛可导致身体、功能和情绪障碍。中医疗法已被证明是治疗慢性背痛的干预手段。此研究旨在临床评价耳针配合拔罐治疗慢性背痛的疗效。

     慢性背痛被认为是世界性的主要公共健康问题除了影响受影响者的生产力和生活质量,并在个人、家庭、企业和政府层面产生经济负担之外,它还与身体、功能和情感上的残疾有关。目前慢性疼痛无法治愈。与急性疼痛的治疗相比,非药物治疗更常用于慢性疼痛的治疗。中医疗法已被证明是治疗慢性背痛的干预手段。此研究旨在临床耳针配合拔罐治疗慢性背痛的疗效。

    实验采用开放标签、随机、平行组对照临床试验。根据CONSORT声明的建议,198名参与者被随机分为“耳针”和“耳针和拔罐”两组。在三个不同的点收集数据;第一次治疗前(初始),最后一次治疗后(最终),治疗结束后7天(随访)。数据收集使用简短疼痛量表、数字痛觉仪和罗兰·莫里斯残疾问卷。广义估计方程模型被用来检验干预和主要结局疼痛严重程度之间的关系。结果:两组患者的疼痛严重程度、压力痛阈和身体残疾均随时间改善。

    然而,对于同时接受耳针和拔罐治疗的患者,在最初和最后的治疗期间,疼痛严重程度、疼痛缓解和身体残疾均有显著变化。对于“耳针和拔罐疗法”组,在后续治疗中疼痛缓解和身体残疾方面也出现了显著变化。

     耳针和拔罐疗法相结合治疗慢性背痛是有效的。拔火罐疗法在最后一次治疗中将耳针对疼痛结果的影响提高了24%,在后续治疗中提高了30%。这些结果是创新的,强调了耳针和拔罐疗法相结合在治疗慢性背痛方面的好处,特别是改善了疼痛导致的身体残疾。未来需要研究耳针和拔罐疗法在不同医疗环境中的效果,以提供更一致的科学证据,证明这些疗法对慢性背部疼痛控制的有效性。

     综上所述,在此研究中,耳针和拔罐疗法结合的抗伤害性作用使“耳针和拔罐疗法”组患者的疼痛严重程度大大降低。这两种干预措施可能被认为是替代疗法,有助于治疗、康复和预防慢性背痛,并改善生活质量。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1783257, encodeId=902c1e8325703, content=<a href='/topic/show?id=684e48445f' target=_blank style='color:#2F92EE;'>#clinical trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4844, encryptionId=684e48445f, topicName=clinical trial)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Nov 13 17:16:37 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748517, encodeId=8dc71e4851759, content=<a href='/topic/show?id=01b55366362' target=_blank style='color:#2F92EE;'>#慢性背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53663, encryptionId=01b55366362, topicName=慢性背痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e36152420, createdName=zhanglin3091, createdTime=Sat Apr 09 12:16:37 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342057, encodeId=c8c7134205ecb, content=<a href='/topic/show?id=c0b8835e6c5' target=_blank style='color:#2F92EE;'>#背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83576, encryptionId=c0b8835e6c5, topicName=背痛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507776, encodeId=5e12150e77638, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631328, encodeId=eb8016313286b, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007011, encodeId=7f02100e0111c, content=哪本期刊?, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60dd2075782, createdName=1521f1182fm, createdTime=Wed Aug 11 18:36:02 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006975, encodeId=e27f10069e550, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df35570302, createdName=ms3000001045083361, createdTime=Wed Aug 11 15:47:39 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1783257, encodeId=902c1e8325703, content=<a href='/topic/show?id=684e48445f' target=_blank style='color:#2F92EE;'>#clinical trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4844, encryptionId=684e48445f, topicName=clinical trial)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Nov 13 17:16:37 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748517, encodeId=8dc71e4851759, content=<a href='/topic/show?id=01b55366362' target=_blank style='color:#2F92EE;'>#慢性背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53663, encryptionId=01b55366362, topicName=慢性背痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e36152420, createdName=zhanglin3091, createdTime=Sat Apr 09 12:16:37 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342057, encodeId=c8c7134205ecb, content=<a href='/topic/show?id=c0b8835e6c5' target=_blank style='color:#2F92EE;'>#背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83576, encryptionId=c0b8835e6c5, topicName=背痛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507776, encodeId=5e12150e77638, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631328, encodeId=eb8016313286b, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007011, encodeId=7f02100e0111c, content=哪本期刊?, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60dd2075782, createdName=1521f1182fm, createdTime=Wed Aug 11 18:36:02 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006975, encodeId=e27f10069e550, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df35570302, createdName=ms3000001045083361, createdTime=Wed Aug 11 15:47:39 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1783257, encodeId=902c1e8325703, content=<a href='/topic/show?id=684e48445f' target=_blank style='color:#2F92EE;'>#clinical trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4844, encryptionId=684e48445f, topicName=clinical trial)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Nov 13 17:16:37 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748517, encodeId=8dc71e4851759, content=<a href='/topic/show?id=01b55366362' target=_blank style='color:#2F92EE;'>#慢性背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53663, encryptionId=01b55366362, topicName=慢性背痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e36152420, createdName=zhanglin3091, createdTime=Sat Apr 09 12:16:37 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342057, encodeId=c8c7134205ecb, content=<a href='/topic/show?id=c0b8835e6c5' target=_blank style='color:#2F92EE;'>#背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83576, encryptionId=c0b8835e6c5, topicName=背痛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507776, encodeId=5e12150e77638, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631328, encodeId=eb8016313286b, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007011, encodeId=7f02100e0111c, content=哪本期刊?, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60dd2075782, createdName=1521f1182fm, createdTime=Wed Aug 11 18:36:02 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006975, encodeId=e27f10069e550, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df35570302, createdName=ms3000001045083361, createdTime=Wed Aug 11 15:47:39 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1783257, encodeId=902c1e8325703, content=<a href='/topic/show?id=684e48445f' target=_blank style='color:#2F92EE;'>#clinical trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4844, encryptionId=684e48445f, topicName=clinical trial)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Nov 13 17:16:37 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748517, encodeId=8dc71e4851759, content=<a href='/topic/show?id=01b55366362' target=_blank style='color:#2F92EE;'>#慢性背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53663, encryptionId=01b55366362, topicName=慢性背痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e36152420, createdName=zhanglin3091, createdTime=Sat Apr 09 12:16:37 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342057, encodeId=c8c7134205ecb, content=<a href='/topic/show?id=c0b8835e6c5' target=_blank style='color:#2F92EE;'>#背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83576, encryptionId=c0b8835e6c5, topicName=背痛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507776, encodeId=5e12150e77638, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631328, encodeId=eb8016313286b, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007011, encodeId=7f02100e0111c, content=哪本期刊?, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60dd2075782, createdName=1521f1182fm, createdTime=Wed Aug 11 18:36:02 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006975, encodeId=e27f10069e550, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df35570302, createdName=ms3000001045083361, createdTime=Wed Aug 11 15:47:39 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-13 zll0628
  5. [GetPortalCommentsPageByObjectIdResponse(id=1783257, encodeId=902c1e8325703, content=<a href='/topic/show?id=684e48445f' target=_blank style='color:#2F92EE;'>#clinical trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4844, encryptionId=684e48445f, topicName=clinical trial)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Nov 13 17:16:37 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748517, encodeId=8dc71e4851759, content=<a href='/topic/show?id=01b55366362' target=_blank style='color:#2F92EE;'>#慢性背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53663, encryptionId=01b55366362, topicName=慢性背痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e36152420, createdName=zhanglin3091, createdTime=Sat Apr 09 12:16:37 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342057, encodeId=c8c7134205ecb, content=<a href='/topic/show?id=c0b8835e6c5' target=_blank style='color:#2F92EE;'>#背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83576, encryptionId=c0b8835e6c5, topicName=背痛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507776, encodeId=5e12150e77638, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631328, encodeId=eb8016313286b, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007011, encodeId=7f02100e0111c, content=哪本期刊?, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60dd2075782, createdName=1521f1182fm, createdTime=Wed Aug 11 18:36:02 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006975, encodeId=e27f10069e550, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df35570302, createdName=ms3000001045083361, createdTime=Wed Aug 11 15:47:39 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-13 feifers
  6. [GetPortalCommentsPageByObjectIdResponse(id=1783257, encodeId=902c1e8325703, content=<a href='/topic/show?id=684e48445f' target=_blank style='color:#2F92EE;'>#clinical trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4844, encryptionId=684e48445f, topicName=clinical trial)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Nov 13 17:16:37 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748517, encodeId=8dc71e4851759, content=<a href='/topic/show?id=01b55366362' target=_blank style='color:#2F92EE;'>#慢性背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53663, encryptionId=01b55366362, topicName=慢性背痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e36152420, createdName=zhanglin3091, createdTime=Sat Apr 09 12:16:37 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342057, encodeId=c8c7134205ecb, content=<a href='/topic/show?id=c0b8835e6c5' target=_blank style='color:#2F92EE;'>#背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83576, encryptionId=c0b8835e6c5, topicName=背痛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507776, encodeId=5e12150e77638, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631328, encodeId=eb8016313286b, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007011, encodeId=7f02100e0111c, content=哪本期刊?, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60dd2075782, createdName=1521f1182fm, createdTime=Wed Aug 11 18:36:02 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006975, encodeId=e27f10069e550, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df35570302, createdName=ms3000001045083361, createdTime=Wed Aug 11 15:47:39 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-11 1521f1182fm

    哪本期刊?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1783257, encodeId=902c1e8325703, content=<a href='/topic/show?id=684e48445f' target=_blank style='color:#2F92EE;'>#clinical trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4844, encryptionId=684e48445f, topicName=clinical trial)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Nov 13 17:16:37 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1748517, encodeId=8dc71e4851759, content=<a href='/topic/show?id=01b55366362' target=_blank style='color:#2F92EE;'>#慢性背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53663, encryptionId=01b55366362, topicName=慢性背痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e36152420, createdName=zhanglin3091, createdTime=Sat Apr 09 12:16:37 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342057, encodeId=c8c7134205ecb, content=<a href='/topic/show?id=c0b8835e6c5' target=_blank style='color:#2F92EE;'>#背痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83576, encryptionId=c0b8835e6c5, topicName=背痛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507776, encodeId=5e12150e77638, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631328, encodeId=eb8016313286b, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Fri Aug 13 04:16:37 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007011, encodeId=7f02100e0111c, content=哪本期刊?, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60dd2075782, createdName=1521f1182fm, createdTime=Wed Aug 11 18:36:02 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006975, encodeId=e27f10069e550, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9df35570302, createdName=ms3000001045083361, createdTime=Wed Aug 11 15:47:39 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-11 ms3000001045083361

    学习

    0

相关资讯

Ann Intern Med:尿失禁非药物治疗的临床指南(全科医生必看)

本临床指南由美国内科医师学会(ACP)的专家小组编写,目标人群为尿失禁女性患者,目标读者为内科医师、全科医师和其它临床医师。背景资料尿失禁(UI)的主要症状为尿液不自主流出。数据显示,年轻女性(14~21岁)的UI患病率约为25%,中年和绝经后妇女(40~60岁)约为44%~57%,75岁以上老年女性则高达75%。这些数据可能被严重低估,因为有研究报道,约有一半的UI患者不会寻求治疗。尿失禁与巨大

Medscape:纤维肌痛非药物治疗可获良好效果

JAMA杂志4月16日发表的一篇临床综述表示,目前人们对于纤维肌痛和其他“集中性”疼痛疾病已经有更深入的了解,并提出了有效的治疗方法。早在2012年10月4日在马萨诸塞州的哈佛医学院波士顿贝斯以色列女执事医疗中心大查房中召开的会议上已系统地总结了纤维肌痛的流行病学特点、病理学、诊断标准和治疗方法。 来自密歇根大学的Clauw教授在文章中写道,目前全球有高达2%到8%的人患有纤维肌痛,其临床主要症

Ann Intern Med:腰痛的非药物治疗:美国内科医师学会临床实践指南的系统评价

腰痛非常普遍。医生应选择伤害最小、成本最低的治疗手段。2017年4月,《Ann Intern Med》发布了腰痛的非药物治疗:一项美国内科医师学会(ACP)临床实践指南的系统评价。

BMJ:严重covid-19管理的进展与希望

对SARS-CoV-2感染的管理在继续演变。对于需要住院治疗的患者,死亡率可能很高(高达20%),但在大流行期间已经下降。死亡率取决于许多因素,我们学到了很多,但还有很多要学。

非药物治疗高血压的是与非

“医生,我已经遵从医嘱规律的服用降压药物了,血压就是控制不住,到底怎么回事?是药不好吗?给我换个药吧”。这是医生在接诊高血压患者时常常碰到的一类问题。

ISC2018:卒中后糖尿病的非药物治疗

研究显示,卒中后新发糖尿病发病率要显著高于其他心血管疾病;同时,糖尿病也会增加卒中复发、致死致残和认知功能障碍等风险。目前认为,以下非药物治疗措施对卒中后糖尿病有一定效果。